Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

News > All

Total search results: 17144 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 170 171 172  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Galapagos N.V.. (11/5/20). "Press Release: OncoArendi and Galapagos Enter into Exclusive Collaboration on Chitinase Inhibitors in Fibrosis". Mechelen & Warsaw. 2020-11-05
The Protein Brewery B.V.. (11/3/20). "Press Release: The Protein Brewery Raises € 22 Million Series A investment". Breda. 2020-11-03
Fountain Healthcare Partners. (11/2/20). "Press Release: Fountain Healthcare Partners Announces Final Close of €125 Million for Fund III". 2020-11-02
PerkinElmer, Inc.. (11/2/20). "Press Release: PerkinElmer to Acquire Cell Engineering Company Horizon Discovery for $383 Million (£296 Million)". Waltham, MA. 2020-11-02
Waters Corporation. (11/2/20). "Press Release: Waters Gives More Laboratories Access to Mass Spectrometry with Rapid, Easy, and Compact Radian ASAP System". Milford, MA. 2020-11-02
Oxford BioDynamics plc. (11/2/20). "Press Release: Oxford BioDynamics Announces Strategic Partnership with Boca Biolistics in Order to Advance EpiSwitch Disease Severity Program for COVID-19". Oxford. 2020-11-02
Robocath S.A.S.. (11/2/20). "Press Release: Robocath Finalizes Creation of the Joint Venture with MicroPort through Its Medical Robotic Subsidiary MedBot". Rouen. 2020-11-02
Polyplus-transfection S.A.. (11/2/20). "Press Release: Polyplus-transfection Names Mario Philips as Chief Executive Officer". Illkirch. 2020-11-02
Corlieve Therapeutics S.A.S.. (11/2/20). "Press Release: Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions". Paris. 2020-11-02
Kiadis Pharma N.V.. (11/2/20). "Press Release: Sanofi Offers to Acquire Kiadis for €308 Million". Paris & Amsterdam. 2020-11-02
EuropaBio. (11/2/20). "Press Release: EuropaBio Announces Dr Claire Skentelbery as New Director General of the Association". Brussels. 2020-11-02
Novartis AG. (10/29/20). "Press Release: Novartis Acquires Vedere Bio, Adding Novel Optogenetic Gene Therapy Technology for Treating Blindness". Basel. 2020-10-29
Vedere Bio, Inc.. (10/29/20). "Press Release: Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company". Cambridge, MA. 2020-10-29
Definitive Healthcare, LLC. (10/29/20). "Press Release: Definitive Healthcare Expands into Medical and Scientific Identification with Acquisition of Monocl". Framingham, MA. 2020-10-29
CRISPR Therapeutics AG. (10/28/20). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results". Zug & Cambridge, MA. 2020-10-28
Trenzyme GmbH. (10/28/20). "Press Release: Successful Anniversary Year for Trenzyme – also with Corona. Constance-based Biotechnology Company Trenzyme Celebrates Its 20th Anniversary". Konstanz. 2020-10-28
Galecto, Inc.. (10/28/20). "Press Release: Galecto Announces Pricing of Initial Public Offering". Boston, MA & Copenhagen. 2020-10-28
OpGen, Inc.. (10/28/20). "Press Release: OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators". Gaithersburg, MD & Holzgerlingen. 2020-10-28
EBD Group. (10/28/20). "Press Release: BIO-Europe Digital Startup Slam Winner 2020 – KyNexis Medicine Development". Munich. 2020-10-28
Scope Fluidics S.A.. (10/28/20). "Press Release: Prof. Carl Wittwer – the Legendary Creator of the PCR Technology – Joins the Scope Fluidics Advisory Committee". Warsaw. 2020-10-28
Bayer AG. (10/27/20). "Press Release: Bayer Appoints Dr. Christian Rommel as New Head of Pharmaceuticals Research and Development". Berlin. 2020-10-27
Eagle Genomics Ltd.. (10/27/20). "Press Release: Scientific Knowledge Discovery Platform Pioneer, Eagle Genomics, Closes $9M in Scale-Up Funding as Major Brands Home in on the Microbiome Megatrend". Cambridge. 2020-10-27
Ogilvy. (10/27/20). "Press Release: Ogilvy Appoints Kate Cronin to Global Role as CEO of Ogilvy Health". New York, NY. 2020-10-27
Prokarium Ltd.. (10/27/20). "Press Release: Prokarium Closes $21M Series B Financing Round and Strengthens Board". London. 2020-10-27
TVM Capital Life Science. (10/27/20). "Press Release: TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, Largest Fund in the Firm’s History ". Munich & Montreal. 2020-10-27
Thrive Earlier Detection Corporation. (10/27/20). "Press Release: Exact Sciences to Acquire Thrive Earlier Detection, Becoming a Leader in Blood-Based, Multi-Cancer Screening". Madison, WI & Cambridge, MA. 2020-10-27
Kaffe Bueno ApS. (10/27/20). "Press Release [Blog Post]: Kaffe Bueno Closes €1.1 Million Seed Round to Unlock Coffee’s Health Potential". 2020-10-27
MLM Medical Labs GmbH. (10/26/20). "Press Release: MLM Medical Labs Continues International Growth with Addition of MD Biosciences in the United States". 2020-10-26
Bayer AG. (10/26/20). "Press Release: Bayer Acquires Asklepios BioPharmaceutical to Broaden Innovation Base in Cell and Gene Therapy". Berlin. 2020-10-26
Eternygen GmbH. (10/26/20). "Press Release: Eternygen Announces the First Closing of its Series A2 Funding Round". Berlin. 2020-10-26
Scorpion Therapeutics, Inc.. (10/26/20). "Press Release: Scorpion Therapeutics Launches with $108 Million to Advance Precision Oncology 2.0". Boston, MA. 2020-10-26
NBE Therapeutics AG. (10/26/20). "Press Release: NBE-Therapeutics Commences First Clinical Study of Anti-ROR1 Antibody-Drug Conjugate for Patients with Solid Tumors". Basel. 2020-10-26
Abcam plc. (10/23/20). "Press Release: Abcam Announces Pricing of Offering on Nasdaq". London. 2020-10-23
Gilead Sciences, Inc.. (10/23/20). "Press Release: Gilead Sciences Completes Acquisition of Immunomedics, Inc.". Foster City, CA. 2020-10-23
Life Science Nord Management GmbH. (10/23/20). "Press Release: Industrial Health Economy on a Steady Course in Northern Germany". Hamburg. 2020-10-23
Abcam plc. (10/23/20). "Press Release: Abcam Announces Exercise of Over-allotment Option [not for any jurisdiction where a violation of relevant laws]". London. 2020-10-23
Abcam plc. (10/23/20). "Press Release: Abcam Announces Launch of Offering and Application to List on the Nasdaq Global Market". London. 2020-10-23
ProBioGen AG. (10/22/20). "Press Release: Heidelberg Pharma Contracts ProBioGen for Cell Line Development and Manufacturing Services". Berlin. 2020-10-22
Atea Pharmaceuticals, Inc.. (10/22/20). "Press Release: Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19". Boston, MA. 2020-10-22
Araris Biotech AG. (10/22/20). "Press Release: Araris Biotech Completes CHF 15.2 Million Seed Financing Round". Zürich. 2020-10-22
GenSight Biologics S.A.. (10/22/20). "Press Release: GenSight Biologics Successfully Raises €25 Million in an Oversubscribed Private Placement With US and European Institutional Investors". Paris. 2020-10-22
SparingVision S.A.S.. (10/21/20). "Press Release: SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer". Paris. 2020-10-21
Proteintech Group, Inc.. (10/20/20). "Press Release: Proteintech Acquires ChromoTek, Expanding its Next Generation Antibody Tools". Chicago, IL & Munich. 2020-10-20
Vaccitech Ltd.. (10/20/20). "Press Release: Vaccitech Expands management Team with Hires including CMO and CFO". Oxford. 2020-10-20
Immunic, Inc.. (10/20/20). "Press Release: EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy". Luxembourg, Gräfeling & New York, NY. 2020-10-20
Atbtherapeutics. (10/20/20). "Press Release: Atbtherapeutics Strengthens Its Scientific Advisory Board to Support the Development of its Novel Platform and Portfolio". Belgium. 2020-10-20
Atriva Therapeutics GmbH. (10/20/20). "Press Release: Germany – EIB Backs Atriva Therapeutics with €24 Million for the Development of a Potential COVID-19 Treatment". Germany. 2020-10-20
ProteoNic B.V.. (10/20/20). "Press Release: ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics". Leiden. 2020-10-20
Centogene N.V.. (10/20/20). "Press Release: Centogene Announces Leadership Transition". Cambridge, MA & Rostock. 2020-10-20
Vifor Pharma AG. (10/20/20). "Press Release: Vifor Pharma and Cara Therapeutics Sign US License Agreement for i.v. Korsuva to Treat Dialysis Patients with Pruritus". St. Gallen & Stamford, CT. 2020-10-20
Siemens Healthineers AG. (10/20/20). "Press Release: Siemens Healthineers Invests in the Growth Market India and Drives Digitalization of Healthcare by Setting Up an Innovation Hub in Bengaluru". Erlangen & Bengaluru. 2020-10-20
Selexis S.A.. (10/20/20). "Press Release: JSR Life Sciences Expands Its European Gene-to-GMP Biologics Manufacturing Facilities for Selexis and KBI Biopharma in Geneva, Switzerland". Sunnyvale, CA. 2020-10-20
Topas Therapeutics GmbH. (10/19/20). "Press Release: Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief Executive Officer". Hamburg. 2020-10-19
BioSpecifics Technologies Corporation. (10/19/20). "Press Release: BioSpecifics to be Acquired by Endo Pharmaceuticals". Wilmington, DE. 2020-10-19
Medigene AG. (10/19/20). "Press Release: Medigene and Cytovant Enter into Service Agreement for DC Vaccine Manufacturing Process Development". Planegg-Martinsried. 2020-10-19
Cevec Pharmaceuticals GmbH. (10/19/20). "Press Release: Cevec and Rznomics Sign License Agreement for the Use of CAP® Technology in Manufacturing of Adenoviral Vectors". 2020-10-19
Cyted Ltd.. (10/19/20). "Press Release: Cyted Acquires Pathognomics Ltd to Support Expansion and Scaling of Digital Pathology and Diagnostic Reporting Services". Cambridge. 2020-10-19
Topas Therapeutics GmbH. (10/19/20). "Press Release: Topas Therapeutics Raises €22 Million (~USD 26 Million) in Series B Financing". Hamburg. 2020-10-19
Promethean Particles Ltd.. (10/16/20). "Press Release: Promethean Particles Appoints New CEO to Lead Accelerated Commercialisation". 2020-10-16
NovaBiotics Ltd.. (10/16/20). "Press Release: NovaBiotics Secures £1 Million in Funding from Innovate UK to Support Clinical Development of Nylexa for COVID-19". Aberdeen. 2020-10-16
Selexis S.A.. (10/16/20). "Press Release: Selexis Names Biopharmaceutical Executive Dirk Lange as New Chief Executive Officer". Geneva. 2020-10-16
SmartDyeLivery GmbH. (10/15/20). "Press Release: Successful Multi-million Financing Round for SmartDyeLivery GmbH". Erfurt & Jena. 2020-10-15
Touchlight Genetics Ltd.. (10/15/20). "Press Release: Touchlight Appoints Karen Fallen as CEO of Touchlight DNA Services". Hampton. 2020-10-15
Consilium Strategic Communications Ltd.. (10/15/20). "Press Release: Consilium Strategic Communications Advises Compass Pathways on Its Successful Initial Public Offering". London. 2020-10-15
Galapagos N.V.. (10/15/20). "Press Release: Galapagos and Servier Report Topline Results for ROCCELLA Phase 2 Clinical Trial with GLPG1972/S201086 in Knee Osteoarthritis Patients". Mechelen & Paris. 2020-10-15
Bayer AG. (10/15/20). "Press Release: Leaps by Bayer Leads USD 17 Million Series B Financing in Biotech Company Azitra". Leverkusen & Branford, CT. 2020-10-15
VectivBio AG. (10/15/20). "Press Release: VectivBio Closes $110 Million Crossover Financing to Advance Transformational Medicines for Rare Diseases". Basel. 2020-10-15
Polyphor Ltd.. (10/14/20). "Press Release: Polyphor Receives CARB-X Award of up to USD 18.44 Million to Support Development of New Antibiotic Program". Allschwil. 2020-10-14
ERS Genomics Ltd.. (10/14/20). "Press Release: ERS Genomics Announces agreement with Fasmac to Commercialize CRISPR/Cas9 Research Reagents in Japan". Dublin & Kanagawa. 2020-10-14
Oncopeptides AB. (10/14/20). "Press Release: Oncopeptides Signs € 40 Million Loan Agreement with the EIB". Stockholm. 2020-10-14
RayzeBio, Inc.. (10/14/20). "Press Release: RayzeBio Launches with $45 Million Series A to Advance Portfolio of Targeted Radiopharmaceuticals for Cancer Therapeutics". San Diego, CA. 2020-10-14
Exscientia Ltd.. (10/14/20). "Press Release: Exscientia and Blue Oak Pharmaceuticals Announce Collaboration to Rapidly Discover Innovative Treatments for CNS disorders". 2020-10-14
Rentschler Biopharma SE. (10/14/20). "Press Release: Rentschler Biopharma and ATUM Announce Leap-In Transposase Licensing Agreement for Development of Robust Manufacturing Processes for Complex Therapeutic Proteins". Laupheim, Milford, MA & Newark, CA. 2020-10-14
Siemens Healthineers AG. (10/14/20). "Press Release: Siemens Healthineers Launches Rapid Antigen Test for the Detection of SARS-CoV-2 [Not for publication in the USA] ". Erlangen. 2020-10-14
Ori Biotech Ltd.. (10/14/20). "Press Release: Ori Biotech Raises $30 Million in Series A Financing to Advance Innovation in Cell and Gene Therapy Manufacturing". London & Woodcliff Lake, NJ. 2020-10-14
Twist Bioscience Corporation. (10/13/20). "Press Release: Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies". South San Francisco, CA, Amsterdam & New York, NY. 2020-10-13
Chord Therapeutics S.A.. (10/13/20). "Press Release: Chord Therapeutics Launches with USD 16 Million Series A Financing from Omega Funds". 2020-10-13
MorphoSys AG. (10/13/20). "Press Release: Ad hoc – MorphoSys AG Launches an Offering of approx. EUR 325 Million Convertible Bonds". Planegg. 2020-10-13
Evotec SE. (10/13/20). "Press Release: Mubdala Investment Company and Novo Holdings A/S Invest €250m in Evotec SE". Hamburg. 2020-10-13
Rappta Therapeutics Oy. (10/13/20). "Press Release: Rappta Therapeutics Raises Series A Financing for the Development of Phosphatase 2A Drugs". Helsinki. 2020-10-13
Oxurion N.V.. (10/13/20). "Press Release: Oxurion NV Appoints Tom Graney, CFA as Chief Financial Officer". Leuven & Boston, MA. 2020-10-13
Axol Bioscience Ltd.. (10/13/20). "Press Release: Axol Bioscience Introduces Multi-electrode Array Screening Services for Human iPSC-derived Cells". Cambridge. 2020-10-13
MorphoSys AG. (10/13/20). "Press Release: MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds [Not for US, AU, ZA, JP, et al.]". Planegg. 2020-10-13
Iksuda Therapeutics Ltd.. (10/13/20). "Press Release: Iksuda Therapeutics Enters License Agreement with University of Goettingen to Develop a New Generation of Antibody Drug Conjugates". Newcastle. 2020-10-13
Qiagen N.V.. (10/13/20). "Press Release: Qiagen Reports Strong Preliminary Results for Third Quarter of 2020". Venlo. 2020-10-13
Priothera Ltd.. (10/12/20). "Press Release: Priothera Closes €30 Million Series A Financing to Develop Highly Promising Therapies for Acute Myeloid Leukemia (AML)". Dublin. 2020-10-12
Merck KGaA. (10/12/20). "Press Release: Merck Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA". Darmstadt. 2020-10-12
Carmat S.A.. (10/12/20). "Press Release: Carmat Is Granted €13 Million in National Innovation Funding to Conduct the EFICAS Study in France". Paris. 2020-10-12
BioNTech SE. (10/9/20). "Press Release: Pfizer Canada and BioNTech Initiate Rolling Submission to Health Canada for SARS-CoV-2 Vaccine Candidate BNT162b2". Kirkland, QC & Mainz. 2020-10-09
Precigen, Inc.. (10/9/20). "Press Release: Precigen Announces Merck KGaA, Darmstadt, Germany Increases Ownership Position Through Exercise of Convertible Note". Germantown, MD. 2020-10-09
Merck KGaA. (10/8/20). "Press Release: Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant". Darmstadt. 2020-10-08
Relief Therapeutics Holding AG. (10/8/20). "Press Release: Relief Therapeutics Appoints Industry Veteran, Jack Weinstein, as Chief Financial Officer and Treasurer". Geneva. 2020-10-08
Evotec SE. (10/8/20). "Press Release: Evotec Achieves Milestone in Neurodegeneration Collaboration with Bristol Myers Squibb". Hamburg. 2020-10-08
Rentschler Biopharma SE. (10/7/20). "Press Release: Joining Forces against SARS-CoV-2. Rentschler Biopharma Contributes to Manufacturing of COVID-19 mRNA Vaccine". Laupheim & Milford, MA. 2020-10-07
Sensei Biotherapeutics, Inc.. (10/7/20). "Press Release: Sensei Biotherapeutics Announces $28.5 Million Financing To Advance Clinical Pipeline and Immunophage Platform Targeting Multiple Cancers". Boston, MA & Gaithersburg, MD. 2020-10-07
InSilicoTrials. (10/7/20). "Press Release: Blog Post – United Venture Is the Lead Investor in Our Round A". 2020-10-07
Santhera Pharmaceuticals Holding AG. (10/6/20). "Press Release: Santhera to Discontinue Phase 3 SIDEROS Study and Development of Puldysa in Duchenne Muscular Dystrophy (DMD) and Focus on Vamorolone". Pratteln. 2020-10-06
Servier. (10/6/20). "Press Release: The Servier Group Accelerates Its Digital Transformation and Has Named Virginie Dominguez as Chief Digital Officer". Paris. 2020-10-06
Biocartis Group N.V.. (10/6/20). "Press Release: Biocartis Announces Market Release of SeptiCyte RAPID Test on Idylla". Mechelen. 2020-10-06
Federation Bio. (10/6/20). "Press Release: Federation Bio Launches with $50 Million Series A Financing and Expands Team to Pioneer Diverse Microbial Therapies". South San Francisco, CA. 2020-10-06
next pagenext page 1 2 3 4 ... 170 171 172  next pagenext page



Advertisement

Picture [iito] Plain Stupid Simple 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [iito] Made Without Love 650x80px

» top